Research on keratins in cancer is fraught with challenges. One of the main difficulties is the complexity of the keratin family, with over 50 different types in humans, each with potentially unique roles in cancer biology. Additionally, the same keratin can have different functions depending on the tissue context, making it hard to generalize findings across different types of cancer. Furthermore, the dynamic nature of keratin expression during cancer progression and treatment poses additional challenges for researchers.
